DOMH
Dominari Holdings
--
--(--)
Market Open: --
--
--(--)
Post-Market: --
Signals Analysis
Buy signal 0
Sell signal 1
Significant Net Income Decline
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About DOMH
Dominari Holdings Inc.
A biotechnology company developing a variety of small molecule anticancer and antiviral therapies
725 5th Avenue, 22nd Floor, New York, NY 10022
--
Dominari Holdings Inc., was founded in Delaware in 1967. The company is a holding company engaged in financial services, investment advisory and wealth management, asset management, investment banking, acquiring interests in high-growth industries, and biotechnology and pharmaceutical research and development through its various subsidiaries.
Company Financials
EPS
DOMH has released its 2025 Q1 earnings. EPS was reported at -3.02, versus the expected 0, missing expectations. The chart below visualizes how DOMH has performed over recent quarters, highlighting trends in earnings surprises.
Revenue & Expenses
DOMH has released its 2025 Q1 earnings report, with revenue of 8.11M, reflecting a YoY change of 493.42%, and net profit of -32.49M, showing a YoY change of -497.10%. The Sankey diagram below clearly presents DOMH's revenue sources and cost distribution.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
